<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="http://uk.news.yahoo.com/modules/rss/yrss.xsl"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Yahoo! News: Drugs &amp; Drug Law News | Full Coverage</title>
    <copyright>Copyright &#xA9; 2007 Yahoo! All rights reserved.</copyright>
    <link>http://uk.news.yahoo.com/fc/drugs.html</link>
    <description><![CDATA[Complete Drugs & Drug Law news coverage from Yahoo! News UK. Find videos, pictures and in-depth Drugs & Drug Law commentary in our full coverage news section.]]></description>
    <language>en-en</language>
    <lastBuildDate>Thu, 24 Jul 2008 23:44:00 +0000</lastBuildDate>
    <ttl>5</ttl>
    <image>
      <title>Yahoo! News UK</title>
      <link>http://uk.news.yahoo.com/fc/drugs.html</link>
      <url>http://l.yimg.com/eur.yimg.com/i/uk/any/u/news.gif</url>
      <height>30</height>
      <width>140</width>
    </image>
    <item>
      <media:content url="http://d.yimg.com/i/ng/ne/rtrs/20080724/22/2072459424-hiv-infected-patient-displays-medicine.jpg?x=437&amp;y=295&amp;q=75&amp;sig=3PlACPS92x3Sg6aW4KFgNQ--" height="295" width="437"></media:content>
      <title><![CDATA[Drugs add 13 years to life of HIV patients]]></title>
      <link>http://uk.news.yahoo.com/rtrs/20080724/thl-uk-aids-acc9995.html</link>
      <guid isPermaLink="false">/rtrs/20080724/r_t_rtrs_hl_medicine/thl-uk-aids-acc9995_2</guid>
      <pubDate>Thu, 24 Jul 2008 23:44:00 +0000</pubDate>
      <description><![CDATA[Cocktails of HIV drugs help patients live an average of 13 years longer -- if they are lucky enough to get them, researchers reported on Thursday.]]></description>
      <media:text type="html">Cocktails of HIV drugs help patients live an average of 13 years longer -- if they are lucky enough to get them, researchers reported on Thursday.</media:text>
      <media:credit role="publishing company">Reuters</media:credit>
    </item>
    <item>
      <media:content url="http://d.yimg.com/i/ng/ne/afp/20080724/23/4084103618-lancet-study-blasts-swiss-stance-hiv-protection.jpg?x=436&amp;y=339&amp;q=75&amp;sig=a6GO9b63CjwyFmHi9PLp0w--" height="339" width="436"></media:content>
      <title><![CDATA[Lancet study blasts Swiss stance on HIV protection]]></title>
      <link>http://uk.news.yahoo.com/afp/20080724/thl-health-aids-switzerland-96993ab.html</link>
      <guid isPermaLink="false">/afp/20080724/r_t_afp_hl_other/thl-health-aids-switzerland-96993ab_1</guid>
      <pubDate>Thu, 24 Jul 2008 23:24:00 +0000</pubDate>
      <description><![CDATA[Doctors have unleashed a counterblast to a Swiss panel that said patients with HIV whose infection is curbed by drugs do not pass on the AIDS virus during unprotected sex.]]></description>
      <media:text type="html">Doctors have unleashed a counterblast to a Swiss panel that said patients with HIV whose infection is curbed by drugs do not pass on the AIDS virus during unprotected sex.</media:text>
      <media:credit role="publishing company">AFP</media:credit>
    </item>
    <item>
      <media:content url="http://d.yimg.com/i/ng/ne/afp/20080724/23/3282082406-staying-alive-drug-cocktail-boosts-hiv-survival-13-years.jpg?x=436&amp;y=291&amp;q=75&amp;sig=ZWD1HHN2r6_zzP7JqGY71w--" height="291" width="436"></media:content>
      <title><![CDATA[Staying alive: Drug cocktail boosts HIV survival by 13 years]]></title>
      <link>http://uk.news.yahoo.com/afp/20080724/thl-health-aids-drugs-96993ab.html</link>
      <guid isPermaLink="false">/afp/20080724/r_t_afp_hl_other/thl-health-aids-drugs-96993ab_1</guid>
      <pubDate>Thu, 24 Jul 2008 23:23:00 +0000</pubDate>
      <description><![CDATA[Anti-HIV drugs have slashed death rates among people with the AIDS virus by nearly 40 percent since combination therapy was introduced in 1996, boosting their life expectancy by some 13 years, a study says.]]></description>
      <media:text type="html">Anti-HIV drugs have slashed death rates among people with the AIDS virus by nearly 40 percent since combination therapy was introduced in 1996, boosting their life expectancy by some 13 years, a study says.</media:text>
      <media:credit role="publishing company">AFP</media:credit>
    </item>
    <item>
      <media:content url="" height="" width=""></media:content>
      <title><![CDATA[U.S. urges genetic test before using Glaxo AIDS drug]]></title>
      <link>http://uk.news.yahoo.com/rtrs/20080724/thl-uk-glaxosmithkline-ziagen-8004a53.html</link>
      <guid isPermaLink="false">/rtrs/20080724/r_t_rtrs_hl_company/thl-uk-glaxosmithkline-ziagen-8004a53_1</guid>
      <pubDate>Thu, 24 Jul 2008 16:30:00 +0000</pubDate>
      <description><![CDATA[AIDS patients should be given a genetic test before treatment with GlaxoSmithKline's drug, Ziagen, to see if they face a higher risk of a potentially fatal reaction, U.S. regulators said on Thursday.]]></description>
      <media:text type="html">AIDS patients should be given a genetic test before treatment with GlaxoSmithKline's drug, Ziagen, to see if they face a higher risk of a potentially fatal reaction, U.S. regulators said on Thursday.</media:text>
      <media:credit role="publishing company">Reuters</media:credit>
    </item>
    <item>
      <media:content url="" height="" width=""></media:content>
      <title><![CDATA[Glaxo to invest in diversity]]></title>
      <link>http://uk.news.yahoo.com/rtrs/20080723/thl-uk-glaxo-8004a53.html</link>
      <guid isPermaLink="false">/rtrs/20080723/r_t_rtrs_hl_company/thl-uk-glaxo-8004a53_4</guid>
      <pubDate>Wed, 23 Jul 2008 14:22:00 +0000</pubDate>
      <description><![CDATA[GlaxoSmithKline's new chief executive set out plans to make the world's second largest drugmaker a broader business with lower costs, but kept a cautious view on short-term prospects that dented its shares.]]></description>
      <media:text type="html">GlaxoSmithKline's new chief executive set out plans to make the world's second largest drugmaker a broader business with lower costs, but kept a cautious view on short-term prospects that dented its shares.</media:text>
      <media:credit role="publishing company">Reuters</media:credit>
    </item>
    <item>
      <media:content url="http://d.yimg.com/i/ng/ne/rtrs/20080723/14/3562301757-new-chief-executive-glaxosmithkline-andrew-witty.jpg?x=289&amp;y=399&amp;q=75&amp;sig=dStFVFiRFfI_mBfZl2_qtw--" height="399" width="289"></media:content>
      <title><![CDATA[Top drug companies' earnings beat forecasts]]></title>
      <link>http://uk.news.yahoo.com/rtrs/20080723/thl-uk-pharmaceuticals-results-8004a53.html</link>
      <guid isPermaLink="false">/rtrs/20080723/r_t_rtrs_hl_company/thl-uk-pharmaceuticals-results-8004a53_1</guid>
      <pubDate>Wed, 23 Jul 2008 14:10:00 +0000</pubDate>
      <description><![CDATA[The world's two biggest drugmakers, Pfizer and GlaxoSmithKline , both beat expectations for quarterly earnings on Wednesday, as did Wyeth , indicating the sector's resilience.]]></description>
      <media:text type="html">The world's two biggest drugmakers, Pfizer and GlaxoSmithKline , both beat expectations for quarterly earnings on Wednesday, as did Wyeth , indicating the sector's resilience.</media:text>
      <media:credit role="publishing company">Reuters</media:credit>
    </item>
    <item>
      <media:content url="" height="" width=""></media:content>
      <title><![CDATA[Glaxo chief wants broader group]]></title>
      <link>http://uk.news.yahoo.com/rtrs/20080723/thl-uk-glaxo-8004a53.html</link>
      <guid isPermaLink="false">/rtrs/20080723/r_t_rtrs_hl_company/thl-uk-glaxo-8004a53_2</guid>
      <pubDate>Wed, 23 Jul 2008 11:35:00 +0000</pubDate>
      <description><![CDATA[GlaxoSmithKline's new chief executive plans to make the world's second largest drugmaker a broader business and give it a simplified structure, which will reduce its running costs.]]></description>
      <media:text type="html">GlaxoSmithKline's new chief executive plans to make the world's second largest drugmaker a broader business and give it a simplified structure, which will reduce its running costs.</media:text>
      <media:credit role="publishing company">Reuters</media:credit>
    </item>
    <item>
      <media:content url="" height="" width=""></media:content>
      <title><![CDATA[Glaxo to sell branded generics in emerging markets]]></title>
      <link>http://uk.news.yahoo.com/rtrs/20080723/thl-uk-glaxo-aspen-8004a53.html</link>
      <guid isPermaLink="false">/rtrs/20080723/r_t_rtrs_hl_company/thl-uk-glaxo-aspen-8004a53_2</guid>
      <pubDate>Wed, 23 Jul 2008 11:14:00 +0000</pubDate>
      <description><![CDATA[GlaxoSmithKline, the world's second largest drugmaker, took a bold step into the branded generics marketplace on Wednesday via an alliance with South Africa's Aspen Pharmacare Holdings.]]></description>
      <media:text type="html">GlaxoSmithKline, the world's second largest drugmaker, took a bold step into the branded generics marketplace on Wednesday via an alliance with South Africa's Aspen Pharmacare Holdings.</media:text>
      <media:credit role="publishing company">Reuters</media:credit>
    </item>
    <item>
      <media:content url="" height="" width=""></media:content>
      <title><![CDATA[New Glaxo chief wants broader, lower-cost company]]></title>
      <link>http://uk.news.yahoo.com/rtrs/20080723/thl-uk-glaxo-8004a53.html</link>
      <guid isPermaLink="false">/rtrs/20080723/r_t_rtrs_hl_company/thl-uk-glaxo-8004a53_1</guid>
      <pubDate>Wed, 23 Jul 2008 11:09:00 +0000</pubDate>
      <description><![CDATA[GlaxoSmithKline's new chief executive plans to make the world's second largest drugmaker a broader business and give it a simplified structure, which will reduce its running costs.]]></description>
      <media:text type="html">GlaxoSmithKline's new chief executive plans to make the world's second largest drugmaker a broader business and give it a simplified structure, which will reduce its running costs.</media:text>
      <media:credit role="publishing company">Reuters</media:credit>
    </item>
    <item>
      <media:content url="http://d.yimg.com/i/ng/ne/rtrs/20080723/07/577990528-glaxosmithkline-logo-outside-its-buildings-west-london.jpg?x=436&amp;y=315&amp;q=75&amp;sig=64MSLcWb0QoHpNVDyvfE9Q--" height="315" width="436"></media:content>
      <title><![CDATA[Glaxo enters branded generics market with Aspen]]></title>
      <link>http://uk.news.yahoo.com/rtrs/20080723/thl-uk-glaxo-aspen-8004a53.html</link>
      <guid isPermaLink="false">/rtrs/20080723/r_t_rtrs_hl_company/thl-uk-glaxo-aspen-8004a53_1</guid>
      <pubDate>Wed, 23 Jul 2008 07:37:00 +0000</pubDate>
      <description><![CDATA[GlaxoSmithKline , the world's second largest drugmaker, took a bold step in the branded generics marketplace on Wednesday via an alliance with South Africa's Aspen Pharmacare Holdings .]]></description>
      <media:text type="html">GlaxoSmithKline , the world's second largest drugmaker, took a bold step in the branded generics marketplace on Wednesday via an alliance with South Africa's Aspen Pharmacare Holdings .</media:text>
      <media:credit role="publishing company">Reuters</media:credit>
    </item>
  </channel>
</rss>

<!-- p20.eunews.ukl.yahoo.com uncompressed/chunked Fri Jul 25 08:40:34 GMT 2008 -->
